NCT05846438

Brief Summary

The goal of this clinical trial is to learn whether showering with surgical drain tubes in place after first stage breast reconstruction causes increased risk of infection. The main questions it aims to answer are:

  • Is there an increased risk of infection/complications with showering 48 hours after drain tubes are in place
  • Does showering after 48 hours with drain tubes in place affect quality of life.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
23mo left

Started Mar 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress63%
Mar 2023Mar 2028

Study Start

First participant enrolled

March 15, 2023

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

April 5, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 6, 2023

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2028

Last Updated

May 5, 2026

Status Verified

April 1, 2026

Enrollment Period

5 years

First QC Date

April 5, 2023

Last Update Submit

April 28, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Presence of Post Operative Infection

    The primary outcome measure will be the presence of infection as judged by the non blinded attending surgeon within the 90 day time frame during post operative evaluations. A breast infection is defined as increased erythema, warmth, and pain at the breast or systemic symptoms such as fevers and chills. Breast infections will be treated with a course of IV antibiotics and possible tissue expander removal and breast pocket irrigation and debridement in the operating room. If the attending physician determines that an infection is present any time during the treatment period the patient will be categorized as infected.

    90 days

Secondary Outcomes (1)

  • Quality of Life Survey

    90 days

Study Arms (2)

Showering 48 hours after Surgery

EXPERIMENTAL

Group 1 will be allowed to shower 48 hours after surgery with drain tubes still in place.

Other: Showering 48 hours after surgery

Showering after drain tubes are removed

NO INTERVENTION

Group 2 will not be allowed to shower until drain tubes are removed.

Interventions

The main intervention is allowing patients to shower 48 hours after surgery

Showering 48 hours after Surgery

Eligibility Criteria

Age18 Years - 100 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsThe study will involved patient's undergoing breast reconstruction following mastectomy.
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • undergoing breast surgery with placement of tissue expander and drains, acceptance of protocol and procedures, age \> 18

You may not qualify if:

  • no existing wounds, previous infections related to implant device if delayed, refusal by patient

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Missouri

Columbia, Missouri, 65212, United States

RECRUITING

Related Publications (4)

  • Ogawa H, Tahara S. Postoperative Showering for Patients With Closed Suction Drainage: A Retrospective Cohort Study of Deep Inferior Epigastric Perforator Flap Breast Reconstructions. Cureus. 2022 Mar 30;14(3):e23665. doi: 10.7759/cureus.23665. eCollection 2022 Mar.

    PMID: 35505721BACKGROUND
  • Gowda AU, Chopra K, Brown EN, Slezak S, Rasko Y. Preventing Breast Implant Contamination in Breast Reconstruction: A National Survey of Current Practice. Ann Plast Surg. 2017 Feb;78(2):153-156. doi: 10.1097/SAP.0000000000000822.

    PMID: 27464530BACKGROUND
  • Elder EE, Brandberg Y, Bjorklund T, Rylander R, Lagergren J, Jurell G, Wickman M, Sandelin K. Quality of life and patient satisfaction in breast cancer patients after immediate breast reconstruction: a prospective study. Breast. 2005 Jun;14(3):201-8. doi: 10.1016/j.breast.2004.10.008.

    PMID: 15927829BACKGROUND
  • Hanna KR, Tilt A, Holland M, Colen D, Bowen B, Stovall M, Lee A, Wang J, Drake D, Lin K, Uroskie T, Campbell CA. Reducing Infectious Complications in Implant Based Breast Reconstruction: Impact of Early Expansion and Prolonged Drain Use. Ann Plast Surg. 2016 Jun;76 Suppl 4:S312-5. doi: 10.1097/SAP.0000000000000760.

    PMID: 26914348BACKGROUND

MeSH Terms

Conditions

Infections

Interventions

Postoperative Period

Intervention Hierarchy (Ancestors)

Perioperative PeriodSurgical Procedures, OperativePatient CareHealth ServicesHealth Care Facilities Workforce and Services

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
The study is unblinded.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: The investigators have two groups of patients. Group one will be allowed to shower 48 hours after surgery. Group two will not be allowed to shower until the drains are removed.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Division Chief of Plastic and Reconstructive Surgery

Study Record Dates

First Submitted

April 5, 2023

First Posted

May 6, 2023

Study Start

March 15, 2023

Primary Completion (Estimated)

March 15, 2028

Study Completion (Estimated)

March 15, 2028

Last Updated

May 5, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations